The anti-fatigue effect of 20(R)-ginsenoside Rg3 in mice by intranasally administration

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 11, 2008, Pages 2024-2027

  Tang, Wenyan ^a   Zhang, Yi ^a   Gao, Jing ^a   Ding, Xueying ^a   Gao, Shen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

20(R) ginsenoside Rg3; Anti fatigue; Intranasal administration

Indexed keywords

GINSENOSIDE RG 3; LACTATE DEHYDROGENASE; LACTIC ACID; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; FATIGUE; FIRST PASS EFFECT; GLYCOGEN LIVER LEVEL; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; SWIMMING; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; WEIGHT CHANGE;

ADMINISTRATION, INTRANASAL; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; GINSENOSIDES; MALE; MICE; MICE, INBRED STRAINS; PHYSICAL ENDURANCE; SWIMMING;

EID: 55549145797     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2024     Document Type: Article

References (23)

1. Lewis R., Wake G., Court G., Court J. A., Pickering A. T., Kim Y. C., Perry E. K., Phytother. Res., 13, 59-64 (1999).
2. Karikura M., Miyaze T., Tanizawa H., Takino Y., Chem. Pharm. Bull., 38, 357-361 (1991).
3. Park I. H., Piao L. Z., Kwon S. W., Lee Y. J., Cho S. Y., Park M. K., Park J. H., Chem. Pharm. Bull., 50, 538-540 (2002).
4. Wang T. F., Meng Z. M., J. Chin. Pharm. Univ., 30, 133-135 (1999).
5. Zhang J., Wang S. R., Chen Q. C., J. Jilin Agriculture Univ., 28, 283-284 (2006).
6. Pang H., Wang H. L., Fu L., Su C. Y., Acta Pharm. Sinica, 36, 170-173 (2001).
7. Ugwoke M. I., Verbeke N., Kinget R., J. Pharm. Pharmacol., 53, 3-22 (2001).
8. Edman P., Bjork E., Adv. Drug Deliv. Rev., 8, 165-177 (1992).
9. Turker S., Onur E., Ozer Y., Pharm. World Sci., 26, 137-142 (2004).
10. Zhang Y., "The Studies of Ginsenoside Rg3 on Anti-fatigue Effects," Jilin University, Jilin, 2007.
11. Chen Y., Kong L. D., Xia X., Kung H. F., Zhang L., J. Ethnopharmacol., 96, 451-459 (2005).
12. Ministry of Health, P.R. China, "Technical Standards for Testing and Assessment of Health Food," 2nd ed., People's Medical Publishing House, Beijing, 2003, pp. 203-304.
13. Taylor R., Hayes K. E., Toth L. A., Contemp. Top. Lab. Anim. Sci., 39, 14-17 (2000).
14. Li Y. J., Ji R., Li Y. W., Li Y. P., Han C. H., Zhang J., Chin. J. Public Health, 19, 712-713 (2003).
15. Belluardo N., Westerblad H., Mudó G., Mol. Cell. Neurosci., 18, 56-67 (2001).
16. Lapvetelainen T., Tiihonen A., Koskela P., Lab. Anim. Sci., 4, 172-179 (1997).
17. Tanaka M., Nakamura F., Mizokawa S., Matsumura A., Nozaki S., Watanabe Y., Neurosci. Lett., 352, 159-162 (2003).
18. Tsopanakis A., Pharmacol. Biochem. Behav., 60, 747-751 (1998).
19. Okazaki Y., Ito Y., Kyo K., Tateishi T., Mat. Sci. Eng. A Struct. Mater., 213, 138-147 (1996).
20. Burr J. R., Reinhart G. A., Swenson R. A., Swaim S. E., Vaughn D. M., Bradley D. M., J. Am. Vet. Med. Assoc., 211, 175-179 (1997).
21. Coombes J. S., McNaughton L. R., J. Sports Med. Phys. Fitness, 40, 240-246 (2000).
22. Dorchy H., Rev. Med. Brux., 23, A211-A217 (2002).
23. Wang J. M., Ginsen Research, 13, 2-10 (2001).